CPHI Milan Live: What matters more now?

Raman Sehgal (0:10)

Hey, guys and girls, welcome back to Molecule to Market fresh from CPHI in Milan. And as always, we go inside the outsourcing space of Pharma and Bio Pharma Services, covering every stage of the global drug development and commercialization life cycle. I am your host, Raman Sehgal, and in today's episode, we'll be speaking about the Pharma and Bio Pharma ecosystem with in fact, 11, that's right, 11 experts and leaders from across the sector.

This was a project that was arranged in partnership with the team at Remarketing. Now, those of you that have listened to the podcast for a while may know that I founded that company, Remarketing, back in 2009 Yep, 17 years ago. How old am I?

Remarketing proudly has gone on to become really a leading growth marketing agency for the pharma services sector. The nature of the work it does for clients all over the world is help them figure out who they want to be in the market and help them show up consistently well, leading to profile and lead generation and all that kind of good stuff. Actually, Molecule to Market was a bit of a side project from Remarketing many moons ago, which is where it came about. Nevertheless, the team was a big team at Remarketing, attending CPHI in Milan last week, and they asked me to do something quite fun and kind of do a bit of a roadshow on the first day at CPHI in addition to the panel that you would have heard last week. We went around and tried to get a sense of how people are feeling in the market across the board. It was hilarious. Hannah and I were running from hole to hole along with the schedule, doing these kind of mini interviews that you're going to hear today. Rather than just do kind of a sentiment check of how the market is and how things are going, what we thought we would do is do something a little bit different. For every one of the guests that you hear today, we give them kind of a series of this or that choices. For example, the first one I ask the interviewees was, what's more important, scale or specialization? Clearly, there is no right or wrong answer. It's just interesting to get the perspective of a leader in a different area of the industry. As you'll see by the responses, with most of the answers, you kind of have this sense of, there was one perspective that kind of coupled together and then an alternative perspective at the other end of the spectrum, and then some that were kind of balanced in the middle. The aim was very much to get beyond the usual kind of conference responses and kind of get some kind of predictions and tensions and opinions in terms of where the business is headed. And we also, there's kind of six of those questions that you'll hear in the next kind of 40 minutes or so. And then we finish off with kind of one big question, which is asking the guests where, if they could pay us one bet to define the sector over the next five years, what would it be? So yeah, really, really fun kind of day spent running around the halls at CPHI and in meeting some fantastic leaders from the sector. So let me tell you who our guests are today. By virtue of the editing complications here, before each of the kind of questions, I'll kind of give a bit of an overview of each of the perspectives as well. It's obviously difficult to introduce every single person on every single response. And so we've tried to do it in a kind of more manageable way. So let me tell you who you can expect to see or hear, in fact, in today's kind of conversation. And I'm going not in order of what you'll hear today, but certainly in order of who I actually interviewed on the days. And first up was Maja Pedersen, who is president and chief operating officer at Fujifilm Biotech. Acknowledges the eagle-eared of you will know that Maja was also on my panel in last week's episode. Absolutely phenomenal leader. So, so impressive. So great to have her involved in this. And she was shortlisted for a bunch of awards at the show as well. Next up, we had Hayley Crowe. He was the Exec VP and General Manager of Global Life Sciences at Ecolab. Really, really kind of impressive and energetic character. Really enjoyed interviewing here as part of this little road show.

Next up, we had John Wichelt, who is the Vice President and General Manager at Bridgerton Facility for Kindeva. And no doubt the booth of the show. If anyone saw the Kindeva booth, it was absolutely phenomenal. And I was fortunate enough to get some time with John at the show.